Methylenedioxymethoxyethylamphetamine

From Wikipedia, the free encyclopedia
  (Redirected from MDMEOET)
Jump to navigation Jump to search
Methylenedioxymethoxyethylamphetamine
MDMEOET.png
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C13H19NO3
Molar mass 237.295 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

MDMEOET, or 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also[edit]

References[edit]

  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.

External links[edit]